β-adrenergic stimulation and rapid pacing mutually promote heterogeneous electrical failure and ventricular fibrillation in the globally ischemic heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 308, Issue 9, 2015, Pages H1155-H1170

  Garg, Vivek ^a   Taylor, Tyson ^a,b   Warren, Mark ^a,b   Venable, Paul ^a,b   Sciuto, Katie ^a,b   Shibayama, Junko ^a   Zaitsev, Alexey ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b University of Utah   (United States)

Author keywords

Inexcitability; Myocardial ischemia; Optical mapping; Ventricular fibrillation; adrenergic stimulation

Indexed keywords

DIACETYL OXIME; ISOPRENALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ACTION POTENTIAL; ACUTE HEART INFARCTION; ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; EPICARDIUM; FEMALE; HEART ARREST; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT MODEL; SUDDEN CARDIAC DEATH; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; DEATH, SUDDEN, CARDIAC; DISEASE MODEL; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART PACING; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; HEART VENTRICLE PRESSURE; IN VITRO STUDY; PATHOPHYSIOLOGY; PERFUSION; RABBIT; RISK FACTOR; TIME; VENTRICULAR FIBRILLATION; VOLTAGE SENSITIVE DYE IMAGING;

ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIAC PACING, ARTIFICIAL; DEATH, SUDDEN, CARDIAC; DISEASE MODELS, ANIMAL; FEMALE; HEART CONDUCTION SYSTEM; HEART VENTRICLES; IN VITRO TECHNIQUES; ISOPROTERENOL; MALE; MYOCARDIAL INFARCTION; PERFUSION; RABBITS; RISK FACTORS; TIME FACTORS; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE; VOLTAGE-SENSITIVE DYE IMAGING;

EID: 84929698393     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00768.2014     Document Type: Article

References (62)

1. Akar FG, Aon MA, Tomaselli GF, O-Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest 115: 3527–3535, 2005.
2. Aupetit JF, Frassati D, Bui-Xuan B, Freysz M, Faucon G, Timour Q. Efficacy of a β-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemiaduration. Cardiovasc Res 37: 646–655, 1998.
3. Aupetit JF, Timour Q, Freysz M, Loufoua-Moundanga J, Omar S, Chevrel G, Faucon G. Vulnerability to ventricular fibrillation related to ischaemia: comparison of the acute effects of beta-blockers and calcium antagonists. Arch Int Pharmacodyn Ther 327: 25–39, 1994.
4. Bayes de Luna A, Elosua R. Sudden death. Rev Esp Cardiol 65: 1039–1052, 2012.
5. Blake K, Clusin WT, Franz MR, Smith NA. Mechanism of depolarization in the ischaemic dog heart: discrepancy between T-Q potentials and potassium accumulation. J Physiol 397: 307–330, 1988.
6. Blake K, Smith NA, Clusin WT. Rate dependence of ischaemic myocardial depolarisation: evidence for a novel membrane current. Cardiovasc Res 20: 557–562, 1986.
7. Bourgeois EB, Reeves HD, Walcott GP, Rogers JM. Panoramic optical mapping shows wavebreak at a consistent anatomical site at the onset of ventricular fibrillation. Cardiovasc Res 93: 272–279, 2012.
8. Bovo E, Lipsius SL, Zima AV. Reactive oxygen species contribute to the development of arrhythmogenic Ca2+ waves during b-adrenergic receptor stimulation in rabbit cardiomyocytes. J Physiol 590: 3291–3304, 2012.
9. Bray MA, Wikswo JP. Considerations in phase plane analysis for nonstationary reentrant cardiac behavior. Phys Rev E 65: 051902, 2002.
10. Callaway CW. Epinephrine for cardiac arrest. Curr Opin Cardiol 28: 36–42, 2013.
11. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev 79: 917–1017, 1999.
12. Chen PS, Wu TJ, Ting CT, Karagueuzian HS, Garfinkel A, Lin SF, Weiss JN. A tale of two fibrillations. Circulation 108: 2298–2303, 2003.
13. Clusin WT, Buchbinder M, Ellis AK, Kernoff RS, Giacomini JC, Harrison DC. Reduction of ischemic depolarization by the calcium channel blocker diltiazem. Correlation with improvement of ventricular conduction and early arrhythmias in the dog. Circ Res 54: 10–20, 1984.
14. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of out-of-hospital ventricular fibrillation, 1980–2000. JAMA 288: 3008–3013, 2002.
15. Coetzee WA, Opie LH. Effects of components of ischemia and metabolic inhibition on delayed afterdepolarizations in guinea pig papillary muscle. Circ Res 61: 157–165, 1987.
16. Cranefield PF, Wit AL, Hoffman BF. Conduction of the cardiac impulse: III. Characteristics of very slow conduction. J Gen Physiol 59: 227–246, 1972.
17. Dennis SC, Coetzee WA, de Jong JW, Clusin W, Opie LH. Effects of coronary flow, pacing rate, isoprenaline and diltiazem on ischemic ventricular arrhythmias in guinea pig hearts. J Pharmacol Exp Ther 248: 372–377, 1989.
18. Dominguez G, Fozzard HA. Influence of extracellular K concentration on cable properties and excitability of sheep cardiac Purkinje fibers. Circ Res 26: 565–574, 1970.
19. Gaur N, Rudy Y, Hool L. Contributions of ion channel currents to ventricular action potential changes and induction of early afterdepolarizations during acute hypoxia. Circ Res 105: 1196–1203, 2009.
20. Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation. Nature 392: 75–78, 1998.
21. Hallstrom A, Herlitz J, Kajino K, Olasveengen TM. Treatment of asystole and PEA. Resuscitation 80: 975–976, 2009.
22. Herlitz J, Svensson L, Engdahl J, Silfverstolpe J. Characteristics and outcome in out-of-hospital cardiac arrest when patients are found in a non-shockable rhythm. Resuscitation 76: 31–36, 2008.
23. Hill JL, Gettes LS. Effect of acute coronary artery occlusion on local myocardial extracellular K+ activity in swine. Circulation 61: 768–778, 1980.
24. Hope RR, Williams DO, El-Sherif N, Lazarra R, Scherlag BJ. The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate. Circulation 50: 507–514, 1974.
25. Huelsing DJ, Spitzer KW, Pollard AE. Electrotonic suppression of early afterdepolarizations in isolated rabbit Purkinje myocytes. Am J Physiol Heart Circ Physiol 279: H250–H259, 2000.
26. Hulleman M, Berdowski J, de Groot JR, van Dessel PF, Borleffs CJ, Blom MT, Bardai A, de Cock CC, Tan HL, Tijssen JG, Koster RW. Implantable cardioverter-defibrillators have reduced the incidence of resuscitation for out-of-hospital cardiac arrest caused by lethal arrhythmias. Circulation 126: 815–821, 2012.
27. Ilkhanoff L, Goldberger JJ. Out-of-hospital cardiac arrest: getting beyond the tip of the iceberg. Circulation 126: 793–796, 2012.
28. Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu Rev Physiol 62: 25–50, 2000.
29. Kalifa J, Klos M, Zlochiver S, Mironov S, Tanaka K, Ulahannan N, Yamazaki M, Jalife J, Berenfeld O. Endoscopic fluorescence mapping of the left atrium: a novel experimental approach for high resolution endocardial mapping in the intact heart. Heart Rhythm 4: 916–924, 2007.
30. Killingsworth CR, Wei CC, Dell’Italia LJ, Ardell JL, Kingsley MA, Smith WM, Ideker RE, Walcott GP. Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation. Circulation 109: 2469–2474, 2004.
31. Lakkireddy V, Bub G, Baweja P, Syed A, Boutjdir M, El-Sherif N. The kinetics of spontaneous calcium oscillations and arrhythmogenesis in the in vivo heart during ischemia/reperfusion. Heart Rhythm 3: 58–66, 2006.
32. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie- Rosett J. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121: e46–e215, 2010.
33. Lou Q, Li W, Efimov IR. The role of dynamic instability and wavelength in arrhythmia maintenance as revealed by panoramic imaging with blebbistatin vs. 2,3-butanedione monoxime. Am J Physiol Heart Circ Physiol 302: H262–H269, 2012.
34. Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Col Cardiol 19: 1622–1633, 1992.
35. Molina-Viamonte V, Anyukhovsky EP, Rosen MR. An alpha-1-adrenergic receptor subtype is responsible for delayed afterdepolarizations and triggered activity during simulated ischemia and reperfusion of isolated canine Purkinje fibers. Circulation 84: 1732–1740, 1991.
36. Ng FS, Shadi IT, Peters NS, Lyon AR. Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmias. J Mol Cell Cardiol 59: 67–75, 2013.
37. Olasveengen TM, Samdal M, Steen PA, Wik L, Sunde K. Progressing from initial non-shockable rhythms to a shockable rhythm is associated with improved outcome after out-of-hospital cardiac arrest. Resuscitation 80: 24–29, 2009.
38. O-Rourke B, Ramza BM, Marban E. Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science 265: 962–966, 1994.
39. Pertsov AM, Davidenko JM, Salomonzs R, Baxter WT, Jalife J. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res 72: 631–650, 1993.
40. Peter T, Fujimoto T, Hamamoto H, Mandel WJ. Comparative study of the effect of slow channel inhibiting agents on ischemia-induced conduction delay as relevant to the genesis of ventricular fibrillation. Am Heart J 106: 1023–1028, 1983.
41. Polentini MS, Pirrallo RG, McGill W. The changing incidence of ventricular fibrillation in Milwaukee, Wisconsin (1992–2002). Prehosp Emerg Care 10: 52–60, 2006.
42. Priori SG, Corr PB. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am J Physiol Heart Circ Physiol 258: H1796–H1805, 1990.
43. Priori SG, Yamada KA, Corr PB. Influence of hypoxia on adrenergic modulation of triggered activity in isolated adult canine myocytes. Circulation 83: 248–259, 1991.
44. Rubart M, Zipes DP. Mechanisms of sudden cardiac death. J Clin Invest 115: 2305–2315, 2005.
45. Schömig A, Haass M, Richardt G. Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur Heart J 12: 38–47, 1991.
46. Schwartz PJ, Priori SG, Vanoli E, Zaza A, Zuanetti G. Efficacy of diltiazem in two experimental feline models of sudden cardiac death. J Am Coll Cardiol 8: 661–668, 1986.
47. Shaw RM, Rudy Y. Electrophysiologic effects of acute myocardial ischemia: a theoretical study of altered cell excitability and action potential duration. Cardiovasc Res 35: 256–272, 1997.
48. Shaw RM, Rudy Y. Electrophysiologic effects of acute myocardial ischemia. A mechanistic investigation of action potential conduction and conduction failure. Circ Res 80: 124–138, 1997.
49. Shaw RM, Rudy Y. Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res 81: 727–741, 1997.
50. Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res 114: 1004–1021, 2014.
51. Sirenko S, Maltsev VA, Maltseva LA, Yang D, Lukyanenko Y, Vinogradova TM, Jones LR, Lakatta EG. Sarcoplasmic reticulum Ca2+ cycling protein phosphorylation in a physiologic Ca2+ milieu unleashes a high-power, rhythmic Ca2+ clock in ventricular myocytes: relevance to arrhythmias and bio-pacemaker design. J Mol Cell Cardiol 66: 106–115, 2014.
52. Taylor TG, Venable PW, Booth A, Garg V, Shibayama J, Zaitsev AV. Does the combination of hyperkalemia and KATP activation determine excitation rate gradient and electrical failure in the globally ischemic fibrillating heart? Am J Physiol Heart Circ Physiol 305: H903–H912, 2013.
53. Tovar OH, Bransford PP, Jones JL. Probability of induction and stabilization of ventricular fibrillation with epinephrine. J Mol Cell Cardiol 30: 373–382, 1998.
54. Vaillant F, Dehina L, Dizerens N, Bui-Xuan B, Tabib A, Lauzier B, Chevalier P, Descotes J, Timour Q. Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status. Resuscitation 84: 384–390, 2013.
55. van Alem AP, Post J, Koster RW. VF recurrence: characteristics and patient outcome in out-of-hospital cardiac arrest. Resuscitation 59: 181–188, 2003.
56. Venable PW, Sciuto KJ, Warren M, Taylor TG, Garg V, Shibayama J, Zaitsev AV. Mitochondrial depolarization and asystole in the globally ischemic rabbit heart: coordinated response to interventions affecting energy balance. Am J Physiol Heart Circ Physiol 308: H485–H499, 2015.
57. Venable PW, Taylor TG, Shibayama J, Warren M, Zaitsev AV. Complex structure of electrophysiological gradients emerging during long-duration ventricular fibrillation in the canine heart. Am J Physiol Heart Circ Physiol 299: H1405–H1418, 2010.
58. Verkerk AO, Veldkamp MW, Coronel R, Wilders R, van Ginneken AC. Effects of cell-to-cell uncoupling and catecholamines on Purkinje and ventricular action potentials: implications for phase-1b arrhythmias. Cardiovasc Res 51: 30–40, 2001.
59. Warner MR, Kroeker TS, Zipes DP. Sympathetic stimulation and norepinephrine infusion modulate extracellular potassium concentration during acute myocardial ischemia. Circ Res 71: 1078–1087, 1992.
60. Weiss J, Shine KI. Effects of heart rate on extracellular [K+] accumulation during myocardial ischemia. Am J Physiol Heart Circ Physiol 250: H982–H991, 1986.
61. Weiss J, Shine KI. Extracellular K+ accumulation during myocardial ischemia in isolated rabbit heart. Am J Physiol Heart Circ Physiol 242: H619–H628, 1982.
62. Wengrowski AM, Kuzmiak-Glancy S, Jaimes R 3rd, Kay MW. NADH changes during hypoxia, ischemia, and increased work differ between isolated heart preparations. Am J Physiol Heart Circ Physiol 306: H529–H537, 2014.